Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genomic polymorphisms provide prognostic information in intermediate-risk acute myeloblastic leukemia.

Blood - 15 Jun 2006

Monzo Mariano, Brunet Salut, Urbano-Ispizua Alvaro, Navarro Alfons, Perea Granada, Esteve Jordi, Artells Rosa, Granell Miquel, Berlanga Juan, Ribera Josep M, Bueno Javier, Llorente Andreu, Guardia Ramon, Tormo Mar, Torres Pio, Nomdedéu Josep F, Montserrat Emili, Sierra Jordi

Abstract excerpt

Current prognostic factors for acute myeloblastic leukemia (AML) are not sufficient to accurately predict the group of patients in the intermediate-risk category who will successfully respond to treatment. Distinct patterns of inherited functional genomic polymorphisms might explain part of these heterogeneous prognoses. We used the allelic discrimination method to identify polymorphisms in GSTT1, SULT1C2, CDA,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Disease-Free Survival
Share to Leukemia, Myeloid, Acute

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Leukocyte Count

Share to Multivariate Analysis

Share to Neoplasm Proteins

Share to Recurrence

Share to Remission Induction

Share to Treatment Outcome

Source

Identifiers

PMID: 16507781
DOI: 10.1182/blood-2005-08-3272

Genes

FLT3
XPA
CDA
ERCC1
GSTT1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genomic polymorphisms provide prognostic information in intermediate-risk acute myeloblastic leukemia.PMID 16507781Read ↗

Acute myeloid leukemia outcome: role of nucleotide excision repair polymorphisms in intermediate risk patients.Semantic proximity Read ↗

Pharmacogenetics of outcome in children with acute lymphoblastic leukemia.Semantic proximity Read ↗

DNA repair polymorphisms and outcome of chemotherapy for acute myelogenous leukemia: a report from the Children's Oncology Group.Semantic proximity Read ↗

Concordance of pharmacogenetic polymorphisms in tumor and germ line DNA in adult patients with acute myeloid leukemia.Semantic proximity Read ↗

Genetic variations of DNA repair genes and their prognostic significance in patients with acute myeloid leukemia.Semantic proximity Read ↗

Improving risk stratification of patients with childhood acute lymphoblastic leukemia: Glutathione-S-Transferases polymorphisms are associated with increased risk of relapse.Semantic proximity Read ↗

Analysis of single nucleotide polymorphism C3435T of the multidrug resistance gene MDR1 in acute lymphoblastic leukemia.Semantic proximity Read ↗

Impact of polymorphisms in drug pathway genes on disease-free survival in adults with acute myeloid leukemia.Semantic proximity Read ↗

Polymorphisms in DNA repair genes and therapeutic outcomes of AML patients from SWOG clinical trials.Semantic proximity Read ↗

Pharmacogenetic influence of GST polymorphisms on anthracycline-based chemotherapy responses and toxicity in breast cancer patients: a multi-analytical approach.Semantic proximity Read ↗

Multidrug-related protein 1 (MRP1) polymorphisms rs129081, rs212090, and rs212091 predict survival in normal karyotype acute myeloid leukemia.Semantic proximity Read ↗

Functional C3435T polymorphism of MDR1 gene: an impact on genetic susceptibility and clinical outcome of childhood acute lymphoblastic leukemia.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.